TD Asset Management »

C4 Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $758k 93k 8.17
2023-12-31 $533k 94k 5.65
2023-06-30 $133k 49k 2.75
2023-03-31 $152k 49k 3.14
2022-12-31 $286k 49k 5.90
2022-09-30 $414k 49k 8.54
2022-06-30 $416k 55k 7.54
2022-03-31 $2.6M 107k 24.26
2021-12-31 $3.4M 106k 32.20
2021-09-30 $4.5M 100k 44.68
2021-06-30 $4.1M 96k 43.14
2021-03-31 $2.5M 67k 36.99
2020-12-31 $523k 16k 33.14